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Circadian rhythms enable organisms to co-ordinate biological processes with the predictable 24 h
cycle of day and night. Given that molecular clocks that coordinate such biological timing have
evolved in almost all organisms, it is clear that being synchronous with the external environment
confers competitive advantage. Conversely, it is apparent that being out of phase is detrimental,
resulting in a number of clinical conditions, many of which are linked to metabolic dysfunction.
The canonical clockwork involves a core set of genes that negatively regulate themselves through
a so-called transcription translation feedback loop. However, recent studies describing evolution-
arily conserved oscillations in redox reactions link circadian rhythms to metabolic processes, and
in particular, redox pathways. In this review we describe the evidence for the interaction between
transcriptional loops, redox and metabolism in mammals and suggest the clock may be potential
target for the treatment of disease.
 2014 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
Almost all organisms display behavioural and biochemical
oscillations over a 24 h period. These circadian (Latin; circa-,
‘‘approximately’’, -diem, ‘‘day’’) rhythms are evolutionarily con-
served and driven by the need to synchronise biological activity
with the ever-changing, but predictable, environment of the rotat-
ing Earth. In mammals processes as diverse as temperature and
blood pressure ﬂuctuations, sleep–wake cycles, and glucose and
lipid metabolism, are all under rhythmic control (Fig. 1). Circadian
rhythms are not merely stimulus-evoked responses since they per-
sist in the absence of external cues, they can adjust to local time
(that is, they ‘entrain’ to cues) and the period and amplitude of
the rhythm is not affected by steady-state temperature, a phenom-
enon known as ‘temperature-compensation’. As a result of circa-
dian rhythm organisms are able to temporally segregate
incompatible or competing processes and synchronise periods of
activity, feeding and rest with the solar day [1,2].
This ability to pre-empt environmental changes has been
shown to confer selective advantage to organisms. For example,
cyanobacteria oscillating with endogenous periods matched to an
externally imposed 24 h light–dark cycle reproduce far better than
colonies that are asynchronous [3]. Similarly, Arabidopsis thalianaplants with rhythms matched to the external light cycle grow fas-
ter than mismatched ones [4], and wild type Drosophila melanogas-
ter display greater reproductive ﬁtness than counterparts with
circadian clock mutations [5].
While being synchronous is advantageous, it follows that being
out of phase with the external environment may be detrimental.
Indeed, dysfunction of circadian rhythms as a result of shift work
or neurodegenerative disorders, for example, has been linked to a
wide range of human disease states including depression, pain,
inﬂammation, heart disease, diabetes and cancer [6–11] indicating
the importance of keeping time. Additionally, circadian clocks can
be used to our beneﬁt when treating patients with medicines, as
exempliﬁed by the fact that time of dosing signiﬁcantly affects
both the efﬁcacy and side-effect proﬁle of drug treatments
[12–14]. Most notably, dosing non-steroidal anti-inﬂammatory
drugs (NSAIDs) and statins in the evening reduces toxicity and
improves their efﬁcacy [13,15]. Furthermore, baseline circadian
rhythmicity prior to chemotherapy has been reported to correlate
with therapeutic outcome and survival rates of patients with met-
astatic colorectal cancer, indicating that patients with perturbed
rhythms may respond less favourable [16]. In line with this, a
recent clinical study suggests tolerability of chemotherapy
regimens in advanced cancer patients could be improved by main-
tenance of circadian rhythm following treatment [17]. Therefore, a
better understanding of the circadian clock could have far reaching
implications for human health and for the treatment of pathologi-
cal states.
Fig. 1. Schematic representation of key physiological changes over the circadian
day. Representation of circadian changes in human physiology (adapted from
[112]).
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In mammals the circadian clock is arranged in a hierarchical
manner with a central clock in the brain maintaining the daily
rhythm in accordance with the external environment. This timing
information is then outputted to the periphery to synchronise the
body’s tissue clocks. In mammals the paired suprachiasmatic
nuclei of the hypothalamus (SCN) are the master pacemaker, and
the SCN act as a coordinator for the rest of the body. The SCN are
reset every day by light on the retina, and dedicated monosynaptic
projections terminate in the SCN resulting in activation of various
signalling pathways including transcription of clock genes and
chromatin remodelling [18].
Metabolic activity in the SCN is high during the daytime and
low at night. However, at night the metabolic activity can be
increased by acute exposure to light. Light is the major Zeitgeber
(‘time giver’) in humans and is capable of altering the circadian
phase by up to an hour [19]. Having periods of light and dark is
important for normal physiology. Preterm infants exposed to a
light/dark cycle in intensive care units gain weight faster than
those under traditional continuous light conditions which may
be a result of decreased metabolic demand [20]. Lesions of the
SCN abolish circadian rhythms in drinking and locomotor activity
in rodents [21,22]. Transplantation studies, where intact SCN are
transferred into lesioned animals showed that rhythms in locomo-
tor activity could be re-established and that a soluble factor was
likely to be required for this restoration, rather than the formation
of new neural connections [23]. It was subsequently shown that
epidermal growth factor signalling was a potential candidate for
modulating locomotor activity, since levels of transforming growth
factor-alpha (TGF-a) are rhythmic and exogenous TGF-a inhibited
activity [24].
While the SCN ensure that peripheral clocks are appropriately
synchronised, peripheral tissues oscillate independently of the
SCN. Indeed, isolated tissues exhibit rhythms for several days,
and even weeks, ex vivo [25–27]. In addition, by restricting food
availability in mice, circadian gene expression in the liver can
desynchronise from that in SCN with a phase shift of up to 12 h
[28,29]. In effect, the clock in the liver and that in the SCN are on
opposite cycles. It is likely that this can lead to deleterious conse-
quences when oscillations between central and peripheral clocks
are mismatched. Conversely, restoration of circadian behaviour
by the use of restricted feeding regimes can diminish metabolicabnormalities in the liver, as has been demonstrated, for example,
in a mouse model of Huntington’s disease, whose circadian
rhythms are disrupted as the disease progresses [30]. This under-
lines the functional link between feeding, and therefore metabo-
lism, and circadian rhythmicity.
3. The transcription-translation feedback loop (TTFL) model
Key components of the molecular clock that drive rhythmic
behaviour have been identiﬁed and characterised in numerous
species including ﬂies, molluscs, ﬁsh and mammals [31–33]. While
there are signiﬁcant differences in their machinery, the logic
appears to be similar, i.e. transcription factors positively induce
‘clock genes’ which then negatively feedback, progressively inhib-
iting transcription, thus forming a ‘transcription-translation feed-
back loop’ (TTFL) [32,34]. In addition, the cycling clock genes of
the TTFL induce numerous other output genes thereby enabling
timing of cellular processes.
In mammals, the master transcription factors BMAL1/2 (brain
and muscle Arnt-like protein) dimerize with CLOCK (circadian
locomotor output cycles kaput), or NPAS2 (Neuronal PAS
domain-containing protein 2) in the brain [35,36] which drives
the transcription of Period (Per1-3) and Cryptochrome (Cry1/2)
genes via interactions with E-box promoter elements [37]. PER
and CRY proteins in turn form complexes in the cytoplasm, and
at a certain threshold, the PER/CRY complex migrates to the
nucleus where it inhibits the action of BMAL and CLOCK, and thus
PER and CRY transcription [38–40]. The inhibitory PER/CRY com-
plexes are subsequently degraded in the proteasome following
phosphorylation by casein kinase Ie (CKIe) [41] and then ubiquiti-
nation [42] which removes the inhibition on CLOCK and BMAL,
allowing the feedback loop to restart again in a 24 h loop.
The system is further ﬁne-tuned by complex interactions with
numerous other intertwined feedback loops. Critically, the retinoic
acid receptor-related orphan receptors, REV-ERBa/b and RORa
bind to enhancer elements on the Bmal1 promoter to inhibit or
promote transcription, respectively [43]. Oscillations in transcrip-
tion of REV-ERBa and RORa drive the rhythmic expression of
BMAL1, and the BMAL1/CLOCK complex acts directly on the
REV-ERBa gene, driving an ‘accessory’ loop (Fig. 2).4. Genome-wide circadian gene expression
An additional layer of regulation is provided by genome-level
sculpting of gene expression at both the level of epigenetics and
transcription. Epigenetic control plays a role in ﬁne tuning the cir-
cadian clock, and accordingly, histone modiﬁcation has been
shown to be an integral part of the TTFL [44,45]. PER/CRY multi-
mers, for example, recruit a PSF/Sin3-HDAC protein complex which
inhibits transcription of deacetylating histones 3 and 4 thereby
altering downstream gene expression [46]. It has also recently
been shown that circadian gene oscillation can be abolished in A.
thaliana by inhibition of histone acetylation and trimethylation
[47] indicating the importance of post-translational modiﬁcations
on clock gene activation.
Microarray experiments (and more recently RNA sequencing
approaches) have been useful in elucidating the temporal nature
of global gene expression. A range of studies have shown that a sig-
niﬁcant proportion of genes are expressed in a circadian manner
and that there are tissue-speciﬁc variations in their expression pat-
tern. It has been reported that 7–21% active genes oscillate in liver
and adipose tissue [48]. However, expression patterns differ
between tissues. For example, in the heart, genes are expressed
in a synchronous manner with similar peak expression proﬁles,
while in the liver, genes showed a broad distribution of expression
Fig. 2. Schematic representation of the core circadian clock. BMAL and CLOCK transcription products translocate to the cytoplasm and dimerize. They then return to the
nucleus binding to E-box regions and promoting Period (PER), Cryptochrome (CRY), REV-ERB and ROR transcription. PER and CRY translocate to the cytoplasm, dimerize and
return to the nucleus inhibiting the binding of the CLOCK/BMAL complex. PER and CRY are subsequently degraded following binding to casein kinase Ie (CKIe) and Fbxl3
respectively. REV-ERB inhibits transcription of Bmal1 whilst ROR promotes Bmal1 expression.
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under circadian control differ between tissues. Of the 650 genes
that were determined to be expressed rhythmically in the SCN
and liver, only 28 were found to overlap between tissues [50]. Such
studies are also useful in elucidating the interaction between circa-
dian genes. This is illustrated by the fact that the links to REV-ERBa
and ROR in the clockwork were no doubt accelerated by the discov-
ery that the REV-ERBa/ROR response elements generate gene
expression in phase with Bmal1 and antiphase with Per2 in both
the SCN and liver [51]. Recent studies using genome-wide cistro-
mic assays have shown RORc directly regulates metabolic gene
transcription and mice deﬁcient in RORc display improved insulin
sensitivity and glucose tolerance [52]. This suggests antagonist for
RORc may be useful for the treatment of metabolic disease.
5. Nuclear receptors
It should be noted that REV-ERB and ROR are not the only
nuclear receptors that are expressed in a circadian manner. Indeed,
more than 50% of nuclear receptors are rhythmically expressed
[53]. Since nuclear receptors usually modulate transcription, they
are likely involved in the circadian expression of their target genes.
For example, glucocorticoid receptors (GR) interacting with CRY1
and CRY2 are involved in repression of glucocorticoid synthesis
[54] and low levels of corticosteroid are able to enhance expression
of Per1 via GR [55].
The clinically-important PPAR (peroxisome proliferator-acti-
vated receptors) family of nuclear receptors are also under clock
regulation. All three isoforms of PPAR display rhythmic expression,
and PPARa is a direct target for CLOCK and BMAL1 [53,56,57]. Fur-
thermore, the rhythmic expression of liver PPARa is disrupted in
Clock and Bmal1 mutant mice [58] and reciprocally, PPARa knock-
out mice display altered hepatic Bmal1 and Per3 rhythms. This is of
major interest since PPARa and PPARc ligands, such as cloﬁbrate
and rosiglitazone, are currently used clinically to reduce lipidlevels and improve glycaemic control, respectively. Such metabolic
disorders have been linked independently to circadian disruption,
but an open question is whether these drugs exert their effect
via modulation of the circadian clockwork. However, there is grow-
ing interest in targeting nuclear receptors for clinical indications
and new compounds could, at the very least, be useful pharmaco-
logical tools to tease apart the interactions between the clock and
nuclear receptors [59,60].
6. Post-translational modiﬁcations
Post-transcriptional and post-translational modiﬁcations (such
as phosphorylation, acetylation, methylation, SUMOylation and
ubiquitination) are integral to the molecular mechanism of the
clock [61–63]. Indeed, it is likely that post-transcriptional pro-
cesses play a signiﬁcant role in driving tissue-speciﬁc circadian
programmes [2,64–67]. Within the ‘core’ clock machinery itself,
phosphorylation of PER2 promotes complex formation with CRY
which in turn promotes nuclear translocation [68]. Additionally,
phosphorylation of PER1 mediates cellular location [69]. BMAL1
displays rhythmic conjugation to SUMO2/3 (Small Ubiquitin-like
Modiﬁer 2/3), with levels of the complex directly proportional to
transcriptional activity [62]. SUMOylation of BMAL1 also promotes
nuclear localisation as well as ubiquitin-dependent degradation. In
the mouse liver, SUMOylation of BMAL1 displays a circadian
rhythm that coincides with its activation [61].
Protein degradation following phosphorylation is an important
timing element of the clock. This is exempliﬁed by the fact that
CRY1/2 degradation is modulated by Fbxl3, an F-box protein with
3 leucine repeats [70]. Mutations in Fbxl3, that reduce the afﬁnity
for CRY, result in mice with a prolonged circadian period of around
27 h. Similarly, PER2 is hyperphosphorylated by casein kinase Ie
(CKIe) [41]. Mutations in CKle, or the phosphorylation site of
PER2 [71], result in decreased degradation of PER2. This presents
in the clinic as familial advanced sleep phase syndrome (FASPS) a
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sleep onset (18:00–20:00) and early awakening (03:00) [41,71].
Interestingly, sleep disturbance is also a common complaint in sev-
eral neurodegenerative diseases [72] with recent studies implicat-
ing a role of clock genes; Alterations in Bmal1 expression proﬁles
have been observed in patients with Parkinson’s [73] and polymor-
phisms in CLOCK has been shown to be a risk factor for the
development Alzheimer’s [74,75].
7. Redox and the clock
The possible interplay between redox state and circadian
rhythm has been long known but it was unclear until recently
whether redox oscillations are a driver of the clock, are an
accessory loop, or a biomarker of cellular time. The discovery that
circadian redox oscillations appear to be conserved throughout
evolution, and that circadian oscillations in redox parameters per-
sist in the absence of transcriptional apparatus, has strengthened
the fundamental link between metabolic processes and the molec-
ular clock [76–78].
Circadian rhythms have been observed in cyanobacteria
Synechococcus elongatus in the absence of transcription and trans-
lation [79]. Three proteins, KaiA, KaiB and KaiC, undergo rhythmic
changes in phosphorylation state [80]. Remarkably, an in vitro
clock can be created; with just these three proteins and ATP as
an energy source phosphorylation of KaiC cycles over a 24 h period
[81]. As cyanobacteria are photosynthetic they need to maintain
synchronicity to the external light environment. In photosynthetic
organisms the redox state of quinone compounds varies in
response to light. It was discovered that the protein LdpA senses
the redox state of the cell which is reduced in high light conditions
and increased in low light. In redox dependent manner LdpA
modulates levels of CikA which associates with and alters the
phosphorylation state of KaiA which in turn alters the rhythm of
the cell to ﬁt external cues [82,83]. Indeed, artiﬁcially altering
the redox state of the cell by addition of quinone compounds can
alter and/or reset the phase of Synechococcus cultures in a similar
manner to altering light levels.
Similarly, in zebraﬁsh light exposure alters redox state, which
increases expression of Cry1 and Per1 orthologues, which is in turn
reciprocally related to catalase expression. This further under-
scores the role of hydrogen peroxide (H2O2) as an intermediate
signal between light and gene expression [84].
In mammals, oscillations in FAD and NADP redox state have
been observed in SCN tissue slices, and these were able to alter
the excitability of SCN neurons through non-transcriptional
modulation of membrane potassium channels [85]. Additionally,
reducing extracellular potassium and calcium inhibits Per1 expres-
sion in the mouse SCN [86,87] suggesting that redox plays a role in
neuronal excitability. The fact that cycling of redox state may have
functional effects is intriguing and requires further study to deter-
mine if such oscillations drive, or are driven by, circadian rhythms.
Approximately ten thousand genes are known to be under cir-
cadian control in mammals [2,49–51]. Numerous studies have
investigated circadian oscillations in gene expression in key meta-
bolic tissues, including brown fat, liver and skeletal muscle
[2,51,88]. Several key metabolic enzymes are rhythmically
expressed in the liver, for example, including succinate dehydroge-
nase 1, ketohexokinase, aldolase 2, enolase 1 and aconitase [64].
Since numerous metabolic diseases appear to have a circadian-
related dysfunction [7], it follows that core cellular metabolism
and the clock are intimately connected.
Metabolic processes alter the redox balance of cells by produc-
ing oxidants and depleting reducing agents. Due to the potential
damaging nature of oxidants, there are numerous mechanisms thatmaintain homeostasis. Large quantities of hydrogen peroxide are
produced in the endoplasmic reticulum – one molecule of H2O2
is generated for each disulphide bond formed during protein fold-
ing [89,90], and large quantities of H2O2 are produced during mito-
chondrial metabolic processes, particularly because of electron
transport leakage releasing O2 radicals. In addition, cytokines
and growth factors stimulate H2O2 production via NADPH oxidase,
which is used as a second messenger [91]. While hydrogen
peroxide is a key cytotoxic component of phagocytic immune cell
activity it is also able to modify proteins, lipids and nucleic acids.
Despite the signiﬁcant quantities produced under normal physio-
logical conditions, ROS (reactive oxygen species) are rapidly detox-
iﬁed by scavengers, thus preventing oxidative stress. ROS are
removed by a variety of enzymes such as catalase, SOD (superoxide
dismutase), glutathione peroxidase and peroxiredoxins, as well as
by Vitamin C and E, carotenoids and lipoic acid [92–94]. Imbalance
in ROS homeostatic mechanisms has been implicated in neurode-
generative conditions such as Parkinson’s and Alzheimer’s disease
[93].
Another endogenous antioxidant of circadian interest is the
hormone melatonin which is secreted from the pineal gland with
levels increasing dramatically during the dark, regardless of an
organisms behavioural pattern [95,96]. In diurnal animals melato-
nin may promote sleep, while in nocturnal animals levels are cor-
related with wakefulness. Melatonin has been proposed to be an
antioxidant and is able to scavenge free radicals [97,98], and also
stimulates antioxidant enzymes [99]. In 3T3-L1 pre-adipocytes,
for example, melatonin was shown to enhance the activities of
SOD, as well as glutathione peroxidase and glutathione reductase
in a manner dependent on melatonin receptor 2 [100]. Recently
it has been shown that shift workers have reduced melatonin lev-
els and altered secretion proﬁles which may lead to increased risk
of cancer [101]. Additionally, melatonin levels are reduced in
patients with type 1 diabetes which may be a result of high glucose
concentration altering melatonin production as is seen in diabetic
rats [102].
The redox state of a cell has been shown to be an integral com-
ponent in the regulation of the molecular clock. The DNA binding
of NPAS2 and CLOCK is inﬂuenced by the redox state of NAD(H)
and NHAP(H) as is the NPAS2:BMAL1 heterodimer [103]. NADP
inhibits NPAS2:BMAL1 binding to DNA, in contrast, the NADPH
promotes DNA binding. At a ratio of NADP:NADP(H) of over 75%
NPAS2:BMAL1 DNA binding increases sharply whereas below
75% binding is reduced. This suggests that the metabolic (redox)
state of a cell could directly inﬂuence the core circadian clock.
8. Peroxiredoxins
Peroxiredoxins (PRDXs) are a family of antioxidants that help to
prevent cellular damage resulting from the production of reactive
oxygen species [104–106]. There are six PRDX isoforms (PRDX
1-6) with differing cellular localisation: cytosol (1, 2, 5 and 6) mito-
chondria (3 and 5), peroxisome (5) and the endoplasmic reticulum
(4) [105,107,108].
PRDXs have a redox active cysteine residue that binds H2O2
forming a sulphenic acid. In most cases, a homodimer is formed
by a resolving cysteine at the C-terminus forming a disulphide
bond with the cysteine sulphenic acid. This bond can then be
‘resolved’ by thioredoxin, enabling further catabolism of peroxide
by PRDX. Additionally, the 2-Cys peroxiredoxins (1–4) can be over-
oxidised to sulphinic and sulphonic acids (-SO2/3H) with increasing
H2O2 concentration. Overoxidation stabilises the formation of inac-
tivated pentamers, in effect decamer structures. The decamer may
then be recycled to the active monomer by sulphiredoxin in an
ATP-dependent reaction [92,109,110] (Fig. 3). This cycling of redox
Fig. 3. Schematic representation of the 2-Cys peroxiredoxin reaction with H2O2. (1) PRDX binds H2O2 forming a sulphenic acid. (2) A homodimer is formed by a resolving
cysteine at the C-terminus forming one, and then two (3) disulphide bonds, with the cysteine sulphenic acid. (4) Thioredoxin resolves the disulphide bond enabling further
catabolism of peroxide by PRDX. (5) + (6) Increasing H2O2 concentration causes 2-Cys peroxiredoxins (I–IV) to be hyperoxidised to sulphinic and sulphonic forms, resulting in
overoxidised monomers and dimers. The overoxidised monomers potentially form a decameric structure. (7) Sulphiredoxin recycles PRDX to monomeric forms.
I. Robinson, A.B. Reddy / FEBS Letters 588 (2014) 2477–2483 2481state of PRDX had been shown to follow a circadian rhythm [64],
with two forms of PRDX6 oscillating in antiphase in the liver,
emphasising a role of post-translational modiﬁcation in circadian
rhythmicity. PRDX2 oscillations have also been shown in the
nucleus of keratinocytes with knockdown of PRDX2 resulting in
increased intracellular ROS and induction of PRDX3 [111].
While the core clockwork utilises transcription-translation
feedback loops (TTFLs), the numerous post-translational modiﬁca-
tions outlined above, coupled to the fact that circadian oscillations
can occur in a simple in vitro system [81], suggests transcription is
not required for the induction and maintenance of circadian
rhythms. To assess this, oscillation in redox state of PRDX was used
as a marker of circadian rhythmicity in isolated human red blood
cells. Using western blotting, it was shown that the redox cycle
of PRDXs was circadian, temperature-compensated and able to
be reset to the external environment [77]. Since red blood cells
in mammals are anucleate, and thus devoid of transcriptional
activity, it follows that TTFLs cannot be solely responsible for the
maintenance of the circadian rhythms in complex organisms such
as humans. The redox state of PRDXs is driven by the metabolic
state of the cell, but is independent of transcription, which sug-
gests metabolism itself is also a key driver of circadian rhythm.
9. Concluding remarks
Circadian rhythms are all pervading, being responsible for myr-
iad biochemical, cellular and behavioural processes. The impor-
tance of keeping in time with the changing environment is
evident from the numerous mechanisms that have evolved to keep
track of time. As organisms became more complex and diverged, so
too did the molecular clock. It now appears that cycling of redox
state is central to the development of circadian timing [76].
Therefore, whilst TTFLs are indeed important in the maintenance
of complex circadian phenotypes, and generating transcriptionalprogrammes at a genome scale, metabolism itself is likely to be
at the core of circadian rhythm generation. Regardless of the
details of the intrinsic molecular machinery that generates 24 h
timing, it is clear that being synchronous with the environment
confers biological advantage, while being out of synchrony poses
problems. It is also apparent that unravelling the molecular intrica-
cies of the clockwork could give rise to potential drug targets and
may lead to novel treatments of pervasive diseases, including
cancer, diabetes, obesity and neurodegeneration.
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